The heptalogist at California Pacific Medical Center was part of
helping Vertex receive Federal Drug Administration approval Monday for
Incivek, a “groundbreaking” drug that doubles the chance of curing
hepatitis C cases (up from 40 to 80 percent).
What does the drug do? Incivek
is a drug that works directly on the virus and it helps to prevent
replication of the virus. ... It marks a turning point in the treatment
of hep C, which kills 5,000 to 12,000 Americans a year.